BICO Group AB (publ)
BICO
Rank in Stocks
#17459
BICO Group AB (publ) is a global bio-convergence enterprise, extending its... BICO Group AB (publ) is a global bio-convergence enterprise, extending its operations across North America, Europe, Asia, and other international markets. Its business is segmented into two primary divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions division equips researchers with advanced tools like 3D bioprinters, hybrid microscopes, and instruments for single-cell dispensing and liquid handling. It also supplies essential consumables such as bioinks, reagents, microscope lenses, and specialized software, alongside 3D reconstructed human tissues crucial for regulatory testing. Furthermore, this segment provides specialized services in 3D cell culture, tissue imaging, multiplex imaging, and digital pathology, primarily benefiting pharmaceutical and biotechnology firms. Conversely, the Bioautomation segment caters to industrial clients with precision dispensing and biosensor technologies, while also delivering diagnostic automation and sophisticated robotics solutions to the medical and diagnostics sectors. Beyond these segments, BICO Group's comprehensive portfolio includes solutions for tissue engineering, multi-omics, cell line development, and diagnostics, contributing to a robust industrial ecosystem. Its principal clientele spans the medical, pharmaceutical, and cosmetic industries. Originally established in 2016 as Cellink AB (publ), the company adopted its current name, BICO Group AB (publ), in August 2021. Its headquarters are located in Gothenburg, Sweden.
Share Price
$2.42
Last synced: 2026-11-09
Market Cap
$167.38M
Change (1 day)
-1.57%
Change (1 year)
12.46%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BICO Group AB (publ) (BICO)
Category
Healthcare
EPS for BICO Group AB (publ) (BICO)
EPS as of June 2026 TTM: $-1.20
According to BICO Group AB (publ)'s latest financial reports, its current EPS (TTM) is $-1.20. At the end of 2025 the company had an EPS of $-1.67, a decrease compared to its 2024 EPS of $-0.01.
EPS history for BICO Group AB (publ) from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.20 | -28.14% |
| 2025 | $-1.67 | 22,808.22% |
| 2024 | $-0.01 | -99.56% |
| 2023 | $-1.65 | 32.24% |
| 2022 | $-1.25 | 181.86% |
| 2021 | $-0.44 | 160.00% |
| 2020 | $-0.17 | -10,100.00% |
| 2019 | 0.00 | -59.52% |
| 2018 | 0.00 | 223.08% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -325.00% |
US
|
|
| $4.09 | -440.83% |
IE
|
|
| $9.45 | -887.50% |
US
|
|
| $2.37 | -297.50% |
US
|
|
| $1.77 | -247.50% |
US
|
Questions about BICO Group AB (publ)'s earnings per share (EPS)
What is BICO Group AB (publ)'s earnings per share (EPS)?
BICO Group AB (publ)'s earnings per share (EPS) over the last twelve months is $-1.20, as of Jun 2026.
What was BICO Group AB (publ)'s earnings per share (EPS) in 2025?
In 2025, BICO Group AB (publ)'s earnings per share (EPS) was $-1.67, compared with $-0.01 in 2024.
How has BICO Group AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BICO Group AB (publ)'s earnings per share (EPS) was highest in 2024 ($-0.01) and lowest in 2025 ($-1.67).
How does BICO Group AB (publ)'s earnings per share (EPS) compare with similar companies?
BICO Group AB (publ)'s earnings per share (EPS) ($-1.20) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.